Cover Image
市場調查報告書

Idarubicin 的中國市場

Investigation Report on China Idarubicin Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 337521
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Idarubicin 的中國市場 Investigation Report on China Idarubicin Market, 2010-2019
出版日期: 2015年08月18日 內容資訊: 英文 30 Pages
簡介

Idarubicin 是由義大利的Arca-mone開發的奈米藥物Doxil的類似體,有防止DNA解旋的效果。對L1210白血病和P338白血病、葛氏白血病有效,毒性也低。中國國內的銷售額,從2005年的1400萬人民幣,2014年擴大到8000萬人民幣。

本報告提供中國的Idarubicin 的市場相關分析、關於Idarubicin 的特徵和認證情形、市場整體規模、各企業、各劑型的市場佔有率、價格趨勢、主要製造商簡介、今後的市場成長預測等的調查評估在。

第1章 Idarubicin 的相關概念

  • 適應症
  • 全球市場的銷售情形

第2章 中國的Idarubicin 市場簡介

  • 中國國內的Idarubicin 的專利申請、核準情況
  • 主要製造商
  • 市場規模

第3章 中國國內的Idarubicin 銷售額分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 Idarubicin 的主要廠商的市場佔有率 (過去5年份)

  • 市場佔有率 (以金額為準)
  • 市場佔有率 (以數量為準)

第5章 中國國內的Idarubicin 的劑型 (過去5年份)

  • 各劑型的市場佔有率 (以金額為準)
  • 各劑型的市場佔有率 (以數量為準)

第6章 中國的醫院的Idarubicin 的參照價格

  • Pfizer Hisun Pharmaceutical Co., Ltd
  • Pharmacia&Upjohn (義大利)
  • Pharmacia&Upjohn (Suzhou) Pharmaceutical Co., Ltd
  • Pfizer Inc. (義大利)

第7章 中國國內的Idarubicin 的主要製造商 (過去5年份)

  • Pfizer Hisun Pharmaceutical Co., Ltd
  • Pharmacia&Upjohn (義大利)
  • Pfizer Inc. (義大利)
  • Nerviano Medical Science S.r.l. (義大利)

第8章 中國國內的Idarubicin 市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境的預測

圖表一覽

目錄
Product Code: 1508304

The exact cause of leukemia is yet to be identified with interior decoration pollution, ionizing radiation, drug contamination and virus infection all being the suspect. The increasing incidence of leukemia is growing in China and the number of new cases reaches 40000 each year, among which over 85% belongs to acute leukemia.

Developed by Italian Arca-mone, idarubicin is an analog of daunorubicin with higher fat solubility. Its main metabolite works by preventing DNA unwinding. In preliminary studies, idarubicin turns out to be more effective and less toxic than DNR and DXR in treating L1210 leukemia, P338 leukemia and Gross leukemia. Since 1988, Japan has conducted clinical research on acute leukemia.

As an anti-mitosiss agent, idarubicin is used in the first line treatment of acute nonlymphoblastic leukemia (ANLL) relapse remission and the second line treatment of acute lymphoblastic leukemia (ALL).

According to CRI's market survey, idarubicin enjoys an increasing demand in China with sales value rising from about CNY 14 million in 2005 to over CNY 80 million in 2014 and CAGR during the period of 2010-2014 reaching 22%. And Pfizer Hisun Pharmaceutical Co., Ltd, Pharmacia&Upjohn (IT), Pharmacia&Upjohn (Suzhou) Pharmaceutical Co., Ltd, Pfizer Inc. (IT) and Nerviano Medical Science S.r.l. (IT) occupy the market, among which Pfizer Hisun Pharmaceutical Co., Ltd had the largest market share of over 40% for sales value in 2014.

Research has shown that autologus hematopoietic stem cell transplantation (HSCT) is an effective way to treat ALL. As idarubicin is included in autologus HSCT, its future demand is expected to be great.

Readers can get at least the following information through this report:

  • market size of idarubicin in China
  • competitive landscape of idarubicin market in China
  • price of idarubicin made by different enterprises in China
  • market outlook of idarubicin in China

The author suggests the following groups of people purchase this report:

  • manufacturers of antileukemic agents
  • investors/research institutions interested in Chinese medicine market
  • -any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Idarubicin

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Idarubicin in China

  • 2.1. Patent and Approval Information of Idarubicin in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Idarubicin Sales in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Idarubicin Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Idarubicin in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Idarubicin in Chinese Hospitals in 2014

  • 6.1. Pfizer Hisun Pharmaceutical Co., Ltd
  • 6.2. Pharmacia&Upjohn (Italy)
  • 6.3. Pharmacia&Upjohn (Suzhou) Pharmaceutical Co., Ltd
  • 6.4. Pfizer Inc. (Italy)

7. Major Manufacturers of Idarubicin in Chinese Market, 2010-2014

  • 7.1. Pfizer Hisun Pharmaceutical Co., Ltd
  • 7.2. Pharmacia&Upjohn (Italy)
  • 7.3. Pfizer Inc. (Iyaly)
  • 7.4. Nerviano Medical Science S.r.l. (Italy)

8. Market Outlook of Idarubicin in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Idarubicin in China
  • Chart Idarubicin Sales in China
  • Chart Sales Value of Idarubicin in China, 2010-2014
  • Chart Sales Value of Idarubicin in Some Regions in China, 2010-2014
  • Chart Sales Volume of Idarubicin in China, 2010-2014
  • Chart Sales Volume of Idarubicin in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Idarubicin Enterprises for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Idarubicin Made by Pfizer Hisun in China, 2010-2014
  • Chart Sales Value and Market Share of Idarubicin Made by Pharmacia&Upjohn (IT) in China, 2010-2014
  • Chart Sales Value and Market Share of Idarubicin Made by Pharmacia&Upjohn (Suzhou) in China, 2010-2014
  • Chart Sales Value and Market Share of Idarubicin Injection in China, 2010-2014
  • Chart Sales Value and Market Share of Idarubicin Capsule in China, 2010-2014
  • Chart Price of Idarubicin Made by Pfizer Hisun Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Idarubicin Made by Pharmacia&Upjohn (IT) in Some Chinese Cities in 2014
  • Chart Price of Idarubicin Made by Pharmacia&Upjohn (Suzhou) in Some Chinese Cities in 2014
  • Chart Price of Idarubicin Made by Pfizer (IT) in Some Chinese Cities in 2014
  • Chart Price of Idarubicin Made by Nerviano Medical Science S.r.l. (IT) in Some Chinese Cities in 2014
Back to Top